Use of tri-substituted glycerol compounds for the treatment...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/685 (2006.01) A61K 31/4965 (2006.01) A61K 31/513 (2006.01) A61K 31/52 (2006.01) A61K 31/7048 (2006.01) A61K 45/06 (2006.01) A61P 35/02 (2006.01)

Patent

CA 2673040

The present invention relates to the use of a tri-substituted glycerol compound for the manufacture of a medicament for the treatment of hematological malignancies. The invention also refers to a kit-of-parts comprising such a medicament. Finally, the invention also relates to a corresponding method for the treatment of such conditions as well as to an in vitro method for determining the susceptibility of such malignant cells to a medicament as defined in the invention.

La présente invention concerne l'utilisation d'un composé de glycérol tri-substitué dans la fabrication d'un médicament destiné au traitement des hémopathies malignes. L'invention concerne également un kit de pièces comprenant un tel médicament. Enfin, l'invention concerne un procédé correspondant pour le traitement de tels états, ainsi qu'un procédé in vitro destiné à déterminer la réceptivité de ces cellules malignes à un médicament tel que défini dans la présente invention.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of tri-substituted glycerol compounds for the treatment... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of tri-substituted glycerol compounds for the treatment..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of tri-substituted glycerol compounds for the treatment... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1857615

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.